RBR-723bk5p尚未招募2 期
Evaluation of the effect of Alogliptin in the prevention of type 1 Diabetes Mellitus
niversidade Federal do Ceará0 个研究点开始时间: 2022年8月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 35Y（—）
入选标准
- •Patients of both sexes aged between 18 and 35 years; Confirmed diagnosis of stage 2 autoimmune diabetes mellitus through the presence of 1 or more positive pancreatic islet autoantibodies anti-insulin antibodies, anti-GAD, IA-2, anti-ZnT8A associated with 2 blood glucose values fasting glucose between 100-124 mg/dL or 2 glycated hemoglobin values between 5.7%-6.4% or a fasting glucose between 100-124 mg/dL + 1 glycated hemoglobin value between 5.7%-6.4%
排除标准
- •Pregnant women, breast-feeding women or those who wish to conceive in the last 3 months; Patients with a clinical-laboratory diagnosis of diabetes; Patients on insulin therapy or any other hypoglycemic therapy at the time of inclusion; chronic kidney failure carriers
研究者
相似试验
已完成
不适用
Evaluation of efficacy and safety of Alogliptin in type 2 diabetic patients with chronic kidney diseaseType 2 Diabetic Patients with chronic kidney DiseaseJPRN-UMIN000008133Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine50
招募中
不适用
evaluation of aloGliptin`s eFficacy and saFety based on Renal function StudyType 2 diabetesJPRN-UMIN000006196Kansai Electric Power Hospital20,000
已完成
不适用
Effects of long-term treatment of alogliptin on glycemic control in Japanese patients with type 2 diabetesJPRN-UMIN000015268Akishima Clinic15
已完成
1 期
Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean ParticipantsPharmacokinetics and PharmacodynamicsNCT01391663Takeda48
已完成
3 期
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT00856284Takeda2,639